Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of alfacalcidol 1 µg daily on the number
of fallers in postmenopausal, alendronate-treated, osteopenic or osteoporotic women.
primary outcome = number of fallers (patients with at least one locomotor fall incl.mixed
falls)